Clinical observation of glaucoma trabeculectomy with mitomycin C treatment / 国际眼科杂志(Guoji Yanke Zazhi)
International Eye Science
; (12): 2256-2258, 2014.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-637021
Responsible library:
WPRO
ABSTRACT
AlMTo explore the clinical outcome of trabeculectomy with mitomycin C ( MMC) on glaucoma. METHODS:
A total of 57 patients (95 eyes) of primary glaucoma were randomly divided into two groups, 31 patients ( 54 eyes ) in trabeculectomy with MMC ( T+MMC ) group, which received trabeculectomy with 0. 2mg/mL MMC in surgical sites, and 26 patients ( 41 eyes ) in trabeculectomy ( T ) group. The anterior chamber, bleb, intraocular pressure ( lOP ) and complications were observed. The post-operative follow-up periods ranged between 4 and 6mo.RESULTS:
The mean lOP was 11. 24 ± 3. 73mmHg on 1d in group T+MMC. There was the significant difference compared with preoperative lOP ( P0. 05). At final follow-up, the lOP was significantly different between group T+MMC and group T (16. 15±3. 62mmHg vs 18. 79±5. 27mmHg, P CONCLUSlONTrabeculectomy with MMC for glaucoma can effectively reduce postoperative scar formation of the filtration passage and lower the lOP to a target level with fewer complications.
Full text:
Available
Database:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
International Eye Science
Year:
2014
Document type:
Article